U.S. Consumer Durables Stock News

NasdaqGM:CBFV
NasdaqGM:CBFVBanks

3 Dividend Stocks With Yields Up To 4.3 For Your Portfolio

In the last week, the United States market has stayed flat, yet it is up 28% over the past year with earnings forecast to grow by 16% annually. In this environment, dividend stocks with attractive yields can offer a compelling opportunity for investors seeking income and stability in their portfolios.
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Dollar Tree NASCAR Deal Puts Undervalued Stock’s Brand In Wider Spotlight

Dollar Tree (NasdaqGS:DLTR) has agreed to become the entitlement sponsor of a NASCAR Cup Series race through a new partnership with Speedway Motorsports. The deal also makes Dollar Tree the Official Value Retailer across 10 Speedway Motorsports racetracks and 15 race weekends. This is Dollar Tree's first NASCAR Cup Series race entitlement sponsorship, expanding its presence in major US sports marketing. Dollar Tree, best known for its fixed price discount stores, is moving its brand into a...
NasdaqGS:LNT
NasdaqGS:LNTElectric Utilities

Will Reaffirmed EPS Guidance and Surging Data Center Demand Change Alliant Energy's (LNT) Narrative

In the past quarter ended March 31, 2026, Alliant Energy Corporation reported first-quarter revenue of US$1,184 million and net income of US$224 million, with GAAP EPS rising to US$0.87 from US$0.83 a year earlier while reaffirming its 2026 consolidated ongoing EPS guidance of US$3.36–US$3.46. Alongside these results, Alliant expanded its data center footprint to approximately 3.4 gigawatts of contracted demand through five executed agreements, highlighting how large-load digital...
NYSE:KEY
NYSE:KEYBanks

What KeyCorp (KEY)'s Clearwater Corporate Finance Deal Means For Shareholders

In April 2026, KeyCorp announced it had signed a definitive agreement to acquire UK-based Clearwater Corporate Finance LLP, marking its first deal since activist pressure in 2025 and aiming to expand its middle-market advisory reach between U.S. and Western European clients, subject to regulatory approval and expected to close in the second half of the year. The move highlights KeyCorp’s intent to grow its fee-based advisory footprint in Europe while honoring prior commitments to avoid...
NasdaqGS:PTON
NasdaqGS:PTONLeisure

Assessing Peloton Interactive (PTON) Valuation As Spotify Partnership Expands Global Digital Reach

Peloton Interactive (PTON) has entered a global partnership with Spotify, placing more than 1,400 of its fitness and wellness classes inside Spotify’s new fitness category for Premium subscribers worldwide. See our latest analysis for Peloton Interactive. The Spotify agreement arrives after a 17.03% 1 month share price return, even as the share price is down 12.42% year to date and the 1 year total shareholder return is a 22.21% loss. This suggests recent momentum sits against a weak longer...
NasdaqGS:SRAD
NasdaqGS:SRADHospitality

Assessing Sportradar Group (NasdaqGS:SRAD) Valuation After Short Seller Allegations And Legal Probes

Sportradar Group (SRAD) is under intense scrutiny after activist short sellers Muddy Waters and Callisto Research accused the company of facilitating illegal gambling operations. These allegations have triggered multiple securities law investigations. See our latest analysis for Sportradar Group. At a share price of $13.26, Sportradar Group’s recent momentum has been weak, with a 30 day share price return of 21.77% and a year to date share price return of 43.14%. The 1 year total shareholder...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Is Down 5.8% After EP Litigation Shadows FARAPULSE Trial Data Release - What's Changed

In late April 2026, Boston Scientific reported strong first-quarter results alongside reduced 2026 guidance, while unveiling extensive clinical data from Heart Rhythm 2026 supporting its FARAPULSE pulsed field ablation platform, WATCHMAN left atrial appendage closure devices, and EMBLEM MRI subcutaneous defibrillator. At the same time, multiple securities class actions were filed alleging misleading disclosures about electrophysiology growth, creating a contrast between the company’s...
NYSE:LXP
NYSE:LXPIndustrial REITs

A Look At LXP Industrial Trust (LXP) Valuation After Phoenix Pre Lease And Record Leasing Volumes

LXP Industrial Trust (LXP) has pre-leased its 1.2 million square foot speculative warehouse development in Phoenix to a U.S. unit of a global logistics firm, under a five-year lease beginning in December 2026. See our latest analysis for LXP Industrial Trust. The Phoenix pre-lease comes on the back of record leasing volumes and follows a quarter where LXP reported a net loss. Yet the stock has a 12.45% 1 month share price return and a 36.64% 1 year total shareholder return, indicating...
NYSE:CPT
NYSE:CPTResidential REITs

A Look At Camden Property Trust (CPT) Valuation After Recent Mixed Share Performance

Recent performance snapshot for Camden Property Trust (CPT) Camden Property Trust (CPT) has traded around $104.45, with a one-month return of 3.7% and a past three-month return of 2.3%, while the one-year total return shows an 8.8% decline. Over longer periods, the stock has a three-year total return of 5.8% and a five-year total return of 0.5%, giving investors a mixed performance picture to weigh against current fundamentals. See our latest analysis for Camden Property Trust. Recent share...
NYSE:LW
NYSE:LWFood

Starboard’s Cost Reset Push Could Be A Game Changer For Lamb Weston Holdings (LW)

On April 30, 2026, Starboard Value LP sent a letter to Lamb Weston Holdings’ board urging a reset of company strategy, a stricter cost discipline including zero-based budgeting, and clearer margin-focused targets after what it described as years of underperformance. The activist investor argued that Lamb Weston’s SG&A expense nearly tripling over the past decade despite only modest volume growth signals a need for a deeper overhaul to rebuild credibility and unlock long-term value. Next,...
NYSE:FBP
NYSE:FBPBanks

How Earnings Strength and Capital Returns Will Impact First BanCorp (FBP) Investors

In April 2026, First BanCorp. reported first-quarter results showing year-over-year increases in net interest income to US$220.96 million and net income to US$88.78 million, while also recording slightly lower net charge-offs of US$21.15 million. The company’s board simultaneously declared a quarterly cash dividend of US$0.20 per share payable on June 12, 2026, and confirmed completion of a share repurchase tranche totaling 3,098,456 shares for US$62.8 million under its October 2025 buyback...
NYSE:KRP
NYSE:KRPOil and Gas

A Look At Kimbell Royalty Partners (KRP) Valuation After Upbeat Analyst Earnings Revisions

Analyst optimism and earnings revisions Recent upward revisions to earnings estimates for Kimbell Royalty Partners (KRP) have become a key focus for the stock, as analysts show broad agreement on higher expectations for both the next quarter and the full year. See our latest analysis for Kimbell Royalty Partners. Kimbell Royalty Partners' recent earnings optimism is arriving alongside solid momentum, with a 30 day share price return of 4.74% and a year to date share price return of 28.51%...
NYSE:DK
NYSE:DKOil and Gas

Is Delek US (DK) Balancing Refining Upgrades And Dividends Or Stretching Its Capital Strategy Too Thin?

Delek US Holdings, Inc. reported first-quarter 2026 results with sales of US$2,653.1 million and a net loss of US$201.3 million, while also affirming a US$0.255 quarterly dividend and appointing Amber Russell as Executive Vice President, Refining to oversee its refining operations. Despite the loss widening, the timely, on-budget completion of the Big Spring refinery turnaround and progress on the Enterprise Optimization Plan underscored management’s focus on improving operational...
NasdaqGM:AIP
NasdaqGM:AIPSoftware

Arteris (AIP) Is Up 8.8% After Deepening MIPS RISC-V AI Collaboration - What's Changed

In April 2026, Arteris, Inc. announced an expanded collaboration with MIPS, a GlobalFoundries company, which will integrate Arteris’ FlexGen smart NoC IP and Magillem SoC integration automation software into MIPS’ RISC-V–based platforms for physical AI applications across automotive MCUs, ADAS, robotics, and embedded computing. This deeper integration into the MIPS ecosystem suggests Arteris’ system IP could become an important building block in future AI-enabled SoC designs, broadening its...
NYSE:HP
NYSE:HPEnergy Services

Should Geopolitics-Driven Oil Price Spike Require Action From Helmerich & Payne (HP) Investors?

In late April 2026, Helmerich & Payne, a major land drilling contractor, saw increased investor attention as geopolitical tensions around Iranian port blockades and the UAE’s exit from OPEC pushed oil and gas prices higher, benefiting oilfield service providers. Beyond the immediate commodity shock, this spotlight has sharpened focus on how Helmerich & Payne’s operational efficiency and sector positioning could influence its resilience amid heightened energy-market uncertainty. We’ll now...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Assessing Steel Dynamics (STLD) Valuation After Strong Q1 2026 Results And Share Buybacks

Steel Dynamics (STLD) is back in focus after first quarter 2026 results showed sales of US$5,204.86 million and net income of US$403.44 million, paired with sizeable completed share repurchases. See our latest analysis for Steel Dynamics. The 30-day share price return of 27.23% and year to date share price return of 30.22% suggest strong momentum building, while the 1-year total shareholder return of 74.56% highlights how recent gains compare with a solid multi year run. If strong recent...
NYSE:HUM
NYSE:HUMHealthcare

Should Humana’s (HUM) Lowered 2026 EPS Outlook and Buybacks Prompt a Rethink on Margin Recovery?

In April 2026, Humana Inc. reported first-quarter 2026 results showing revenue of US$39,648 million, net income of US$1,186 million, diluted EPS of US$9.83, and announced completion of a US$276.13 million share repurchase program covering 1% of its shares. On the same day, Humana lowered its full-year 2026 GAAP diluted EPS guidance to at least US$8.36, signaling that profitability expectations have softened even as top-line growth continues. Next, we’ll examine how Humana’s reduced 2026...